AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B streptococcal colonization
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal antibiotics before delivery
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Cesarean section
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative vaginal delivery
Number of subjects: 0
Study 7895956 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal (1300 kcal)
Number of subjects: 12
Study 3300348 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 units of oxytocin diluted in physiologic saline solution (20 ml total volume)
Number of subjects: 78
Study 3300348 — intervention group
Group type: COMPARATOR
Intervention: 20 ml of saline solution alone (control)
Number of subjects: 78
Study 31676303 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 0
Study 31710994 — intervention group
Group type: EXPERIMENTAL
Intervention: Heroin (low, medium, high doses)
Number of subjects: 16
Study 31710994 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone (low, medium, high doses)
Number of subjects: 16
Study 31710994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 27910134 — intervention group
Group type: EXPERIMENTAL
Intervention: Jacky-Like catheter (JLC)
Number of subjects: 387
Study 27910134 — intervention group
Group type: COMPARATOR
Intervention: 2-catheter approach (2C)
Number of subjects: 387
Study 25321623 — intervention group
Group type: EXPERIMENTAL
Intervention: EVG/COBI/FTC/TDF
Number of subjects: 700
Study 25321623 — intervention group
Group type: COMPARATOR
Intervention: EFV/FTC/TDF
Number of subjects: 700
Study 23291270 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone intervention with diaries and therapist feedback
Number of subjects: 140
Study 23291270 — intervention group
Group type: COMPARATOR
Intervention: Control group (no smartphone intervention)
Number of subjects: 140
Study 21802161 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg/d)
Number of subjects: 48
Study 21802161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 21802161 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg/d) and Placebo
Number of subjects: 48
Study 18435210 — intervention group
Group type: EXPERIMENTAL
Intervention: Adson A test
Number of subjects: 0
Study 18435210 — intervention group
Group type: EXPERIMENTAL
Intervention: Adson B test
Number of subjects: 0
Study 18435210 — intervention group
Group type: EXPERIMENTAL
Intervention: Costoclavicular maneuver (CCM)
Number of subjects: 0
Study 18435210 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated arm stress test (Roos)
Number of subjects: 0
Study 18435210 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraclavicular pressure (SCP)
Number of subjects: 0
Study 17323733 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant-supported mandibular overdentures (ISMOs) delivered after 1 week
Number of subjects: 20
Study 17323733 — intervention group
Group type: COMPARATOR
Intervention: Conventional mandibular dentures delivered after 1 week, converted to ISMOs after 3 months
Number of subjects: 20
Study 17323733 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (ISMOs and conventional dentures)
Number of subjects: 20
Study 12970728 — intervention group
Group type: EXPERIMENTAL
Intervention: Transrectal ultrasound-guided needle biopsy without anesthesia
Number of subjects: 131
Study 12970728 — intervention group
Group type: EXPERIMENTAL
Intervention: First core location (Apex biopsy)
Number of subjects: 131
Study 12970728 — intervention group
Group type: EXPERIMENTAL
Intervention: First core location (Base biopsy)
Number of subjects: 131
Study 10900712 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous propranolol (0.92‐1.38 micrograms/kg/min)
Number of subjects: 74
Study 10900712 — intervention group
Group type: EXPERIMENTAL
Intervention: Cordanum (1.85‐2.7 micrograms/kg/min)
Number of subjects: 74
Study 10900712 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.018‐0.037 microgram/kg/min)
Number of subjects: 74
Study 10900712 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalargin (0.55‐0.83 microgram/kg/min)
Number of subjects: 74
Study 10900712 — intervention group
Group type: EXPERIMENTAL
Intervention: HBO-100% O2 for 1 h at 1.5 ATA
Number of subjects: 74
Study 8983567 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-h theophylline (treatment A)
Number of subjects: 20
Study 8983567 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-h theophylline (treatment B)
Number of subjects: 20
Study 8258465 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release theophylline 300 mg + salbutamol 4 mg (Drug I)
Number of subjects: 30
Study 8258465 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 4 mg + theophylline 300 mg (Drug II)
Number of subjects: 30
Study 8258465 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol sustained released (asthalin SA) 8 mg (Drug III)
Number of subjects: 30
Study 8258465 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol sustained released (ventorlin CR) 8 mg (Drug IV)
Number of subjects: 30
Study 8258465 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol alone
Number of subjects: 30
Study 3517744 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine
Number of subjects: 0
Study 3517744 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30895883 — intervention group
Group type: EXPERIMENTAL
Intervention: High Social Interaction (HSI) group
Number of subjects: 10
Study 30895883 — intervention group
Group type: COMPARATOR
Intervention: Low Social Interaction (LSI) group
Number of subjects: 10
Study 29688768 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal compresses
Number of subjects: 500
Study 29688768 — intervention group
Group type: COMPARATOR
Intervention: Hot compresses
Number of subjects: 500
Study 28230020 — intervention group
Group type: EXPERIMENTAL
Intervention: TACE combined with MWA
Number of subjects: 3000
Study 28230020 — intervention group
Group type: COMPARATOR
Intervention: TACE
Number of subjects: 3000
Study 24551257 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency electrocauterization (EC) followed by daily moist-wound-treatment (MWT) with DAC N-055 (group I)
Number of subjects: 113
Study 24551257 — intervention group
Group type: COMPARATOR
Intervention: High-frequency electrocauterization (EC) followed by daily moist-wound-treatment (MWT) without DAC N-055 (group II)
Number of subjects: 113
Study 24551257 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency electrocauterization (EC) with DAC N-055
Number of subjects: 113
Study 24551257 — intervention group
Group type: COMPARATOR
Intervention: High-frequency electrocauterization (EC) without DAC N-055
Number of subjects: 113
Study 24551257 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (group I and group II)
Number of subjects: 113
Study 24551257 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency electrocauterization (EC) with DAC N-055 (group I)
Number of subjects: 113
Study 24551257 — intervention group
Group type: COMPARATOR
Intervention: High-frequency electrocauterization (EC) without DAC N-055 (group II)
Number of subjects: 113
Study 22343153 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine‐motor eye exercises (n=18)
Number of subjects: 27
Study 22343153 — intervention group
Group type: COMPARATOR
Intervention: No exercise (n=9)
Number of subjects: 27
Study 20363903 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to billing time
Number of subjects: 0
Study 20363903 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental manipulation of billing time
Number of subjects: 0
Study 20363903 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual differences in valuing money
Number of subjects: 0
Study 17727960 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate/hard exercise
Number of subjects: 18
Study 17727960 — intervention group
Group type: COMPARATOR
Intervention: Very-light exercise
Number of subjects: 18
Study 15963870 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous morphine
Number of subjects: 11
Study 15963870 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized morphine
Number of subjects: 11
Study 12576806 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 weeks stenting (group 1)
Number of subjects: 57
Study 12576806 — intervention group
Group type: COMPARATOR
Intervention: 4 weeks stenting (group 2)
Number of subjects: 57
Study 10588116 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytosine arabinoside
Number of subjects: 48
Study 10588116 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 48
Study 9171045 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically active toothbrush
Number of subjects: 0
Study 9171045 — intervention group
Group type: COMPARATOR
Intervention: Inactive toothbrush
Number of subjects: 0
Study 8340055 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin (0.8 to 1.0 gm/day)
Number of subjects: 24
Study 8340055 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-beta (3 mU three times a week intravenously)
Number of subjects: 24
Study 8340055 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ribavirin and interferon-beta
Number of subjects: 24
Study 8340055 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study 3089939 — intervention group
Group type: COMPARATOR
Intervention: LAF (laminar air flow isolation)
Number of subjects: 122
Study 3089939 — intervention group
Group type: EXPERIMENTAL
Intervention: LAF + PSA (laminar air flow isolation plus prophylactic systemic antibiotics)
Number of subjects: 122
Study 29300962 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg THC
Number of subjects: 18
Study 29300962 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg THC
Number of subjects: 18
Study 29300962 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg THC
Number of subjects: 18
Study 29300962 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 ng/mL cutoff
Number of subjects: 18
Study 29300962 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ng/mL cutoff
Number of subjects: 18
Study 29300962 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 ng/mL cutoff
Number of subjects: 18
Study 27552840 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention (three participatory workshops and organization-wide educational activities)
Number of subjects: 16
Study 27552840 — intervention group
Group type: COMPARATOR
Intervention: Standard care (print resources)
Number of subjects: 16
Study 25425371 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography in intubated patients under controlled mechanical ventilation (group 1)
Number of subjects: 54
Study 25425371 — intervention group
Group type: EXPERIMENTAL
Intervention: Transthoracic echocardiography in intubated patients under pressure support ventilation (group 2)
Number of subjects: 54
Study 25425371 — intervention group
Group type: EXPERIMENTAL
Intervention: No ventilation support in patients (group 3)
Number of subjects: 54
Study 25425371 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation
Number of subjects: 54
Study 25425371 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypovolemia before the session in patients without mechanical ventilation
Number of subjects: 54
Study 25425371 — intervention group
Group type: COMPARATOR
Intervention: Overall comparison of groups
Number of subjects: 54
Study 23259002 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oil inhalation (lavender, ylang‐ylang, marjoram, neroli blended in a ratio of 20:15:10:2)
Number of subjects: 83
Study 23259002 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oil inhalation
Number of subjects: 83
Study 23259002 — intervention group
Group type: COMPARATOR
Intervention: Placebo (artificial fragrance)
Number of subjects: 83
Study 23259002 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 83
Study 20450989 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative MRCP in group I (125 patients)
Number of subjects: 250
Study 20450989 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy without pre-operative MRCP in group II (125 patients)
Number of subjects: 250
Study 18183613 — intervention group
Group type: EXPERIMENTAL
Intervention: HP eradication therapy (amoxicillin, clarithromycin, and omeprazole) for 2 weeks
Number of subjects: 129
Study 18183613 — intervention group
Group type: EXPERIMENTAL
Intervention: HP eradication therapy
Number of subjects: 129
Study 18183613 — intervention group
Group type: COMPARATOR
Intervention: HP-negative patients
Number of subjects: 129
Study 15925483 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture on acupoints Renyin (Stomach Channel 9), Lieque (Lung Channel 7), and Zhaohai (Kidney Channel 6)
Number of subjects: 24
Study 15925483 — intervention group
Group type: COMPARATOR
Intervention: Placebo acupuncture on acupoints Houxi (Small Intestine Channel 3) and Kunlun (Bladder Channel 60)
Number of subjects: 24
Study 12944595 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg or 40 mg of hyoscine butylbromide
Number of subjects: 136
Study 12944595 — intervention group
Group type: COMPARATOR
Intervention: hyoscine butylbromide
Number of subjects: 136
Study 12944595 — intervention group
Group type: EXPERIMENTAL
Intervention: rectal balloon catheter
Number of subjects: 136
Study 10102972 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalazine 2 g gel enema
Number of subjects: 103
Study 10102972 — intervention group
Group type: COMPARATOR
Intervention: Mesalazine 2 g foam enema
Number of subjects: 103
Study 7928148 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant spraying
Number of subjects: 77
Study 7928148 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fibrin sealant)
Number of subjects: 77
Study 7928148 — intervention group
Group type: COMPARATOR
Intervention: No liver mobilization
Number of subjects: 77
Study 2484394 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (15 ppm anhydrous sodium selenite in table salt)
Number of subjects: 20847
Study 2484394 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 20847
Study 2484394 — intervention group
Group type: COMPARATOR
Intervention: Normal table salt (control)
Number of subjects: 20847
Study 1105752 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar traction
Number of subjects: 0
Study 1105752 — intervention group
Group type: COMPARATOR
Intervention: Control (no traction)
Number of subjects: 0
Study 31387756 — intervention group
Group type: EXPERIMENTAL
Intervention: HIPEC (cisplatin 50 mg/m2 + doxorubicin 50 mg/m2, 42°C, 1 h) combined with radical surgery
Number of subjects: 154
Study 31387756 — intervention group
Group type: COMPARATOR
Intervention: Control group (radical surgery only)
Number of subjects: 154
Study 28029189 — intervention group
Group type: EXPERIMENTAL
Intervention: Group RS (Resilience Light Cure Band Cement)
Number of subjects: 0
Study 28029189 — intervention group
Group type: EXPERIMENTAL
Intervention: Group RMO (RMO Band Cement)
Number of subjects: 0
Study 28029189 — intervention group
Group type: EXPERIMENTAL
Intervention: Group CK (Crosslink Orthodontic Band Cement)
Number of subjects: 0
Study 28029189 — intervention group
Group type: EXPERIMENTAL
Intervention: Group TP (Transbond Plus Light Cure Band)
Number of subjects: 0
Study 28029189 — intervention group
Group type: COMPARATOR
Intervention: Group C (Control-polyethylene)
Number of subjects: 0
Study 26398263 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct training with vocal exercises (DTG, n=13)
Number of subjects: 25
Study 26398263 — intervention group
Group type: COMPARATOR
Intervention: Indirect training with vocal orientations (ITG, n=12)
Number of subjects: 25
Study 23441809 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance training
Number of subjects: 48
Study 23441809 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 48
Study 23441809 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study 21935504 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastomeric-ligated brackets
Number of subjects: 13
Study 21935504 — intervention group
Group type: COMPARATOR
Intervention: Self-ligating brackets
Number of subjects: 13
Study 21935504 — intervention group
Group type: EXPERIMENTAL
Intervention: DIAGNOdent measurements
Number of subjects: 13
Study 21935504 — intervention group
Group type: EXPERIMENTAL
Intervention: Photographic evaluation
Number of subjects: 13
Study 18588449 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel in combination with cisplatin/5-fluorouracil (PF)
Number of subjects: 0
Study 18588449 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin/5-fluorouracil (PF)
Number of subjects: 0
Study 16565124 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision support software
Number of subjects: 36
Study 16565124 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice based workshops
Number of subjects: 36
Study 16565124 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 16565124 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic tutorial
Number of subjects: 36
Study 15799932 — intervention group
Group type: EXPERIMENTAL
Intervention: On-pump technique
Number of subjects: 324
Study 15799932 — intervention group
Group type: COMPARATOR
Intervention: Off-pump technique
Number of subjects: 324
Study 10902462 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol injection (PEI)
Number of subjects: 0
Study 10902462 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency thermal ablation (RFTA)
Number of subjects: 0
Study 10902462 — intervention group
Group type: COMPARATOR
Intervention: Transarterial chemoembolization (TACE)
Number of subjects: 0
Study 10902462 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment strategies (TACE and PEI or RFTA)
Number of subjects: 0
Study 9293628 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative group
Number of subjects: 0
Study 9293628 — intervention group
Group type: COMPARATOR
Intervention: Nominal group
Number of subjects: 0
Study 7955267 — intervention group
Group type: EXPERIMENTAL
Intervention: Maze procedure
Number of subjects: 46
Study 3799443 — intervention group
Group type: EXPERIMENTAL
Intervention: Indecainide, 1 mg/kg intravenously
Number of subjects: 15
Study 3799443 — intervention group
Group type: COMPARATOR
Intervention: Procainamide, 1000 mg intravenously
Number of subjects: 15
Study 30111521 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial access (TRA)
Number of subjects: 931
Study 30111521 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral access (TFA)
Number of subjects: 931
Study 28549637 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal vitamin D supplementation
Number of subjects: 234
Study 28549637 — intervention group
Group type: COMPARATOR
Intervention: Control group (infant vitamin D supplementation)
Number of subjects: 234
Study 26516711 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.014‐inch superelastic NiTi
Number of subjects: 75
Study 26516711 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.014‐inch thermoelastic NiTi
Number of subjects: 75
Study 26516711 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.014‐inch conventional NiTi
Number of subjects: 75
Study 23273227 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive healthy lifestyle program (IHHP)
Number of subjects: 2180000
Study 23273227 — intervention group
Group type: COMPARATOR
Intervention: Reference area
Number of subjects: 2180000
Study 21968670 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical treatment applied weekly for six months
Number of subjects: 63
Study 18617377 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.4 g/day SINETROL
Number of subjects: 20
Study 18617377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 16955182 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical ear acupuncture on right ear
Number of subjects: 32
Study 16955182 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical ear acupuncture on left ear
Number of subjects: 32
Study 16955182 — intervention group
Group type: COMPARATOR
Intervention: No acupuncture (control)
Number of subjects: 32
Study 12729523 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard enteral formula (3 cans/day, 250 ml per can)
Number of subjects: 70
Study 12729523 — intervention group
Group type: COMPARATOR
Intervention: Isolated nutritional counselling (unsupplemented group)
Number of subjects: 70
Study 10671303 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 microg GM‐CSF/kg b.w. daily for 6 weeks
Number of subjects: 45
Study 10671303 — intervention group
Group type: EXPERIMENTAL
Intervention: GM‐CSF/IFNalpha2b combination
Number of subjects: 45
Study 10671303 — intervention group
Group type: COMPARATOR
Intervention: IFNalpha2b monotherapy
Number of subjects: 45
Study 10671303 — intervention group
Group type: EXPERIMENTAL
Intervention: GM‐CSF therapy
Number of subjects: 45
Study 8841206 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 191
Study 8841206 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191
Study 1739366 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin calcium ointment applied to the anterior part of the nares for 5 days
Number of subjects: 0
Study 1739366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6352728 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal size (12.5%, 25%, and 50% of total calories, 30 Kcal/kg)
Number of subjects: 8
Study 6352728 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequence of meal ingestion
Number of subjects: 8
Study 6352728 — intervention group
Group type: COMPARATOR
Intervention: Time of day of meal ingestion
Number of subjects: 8
Study 31560700 — intervention group
Group type: EXPERIMENTAL
Intervention: abacavir/lamivudine + raltegravir
Number of subjects: 46
Study 31560700 — intervention group
Group type: COMPARATOR
Intervention: abacavir/lamivudine + darunavir/r
Number of subjects: 46
Study 29453431 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (HRLGG)
Number of subjects: 0
Study 29453431 — intervention group
Group type: COMPARATOR
Intervention: Placebo (HRP)
Number of subjects: 0